Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.

BMC genomics - 22 Aug 2016

Xu Rong, Wang QuanQiu

Abstract excerpt

BACKGROUND: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and destruction of synovial joints. RA affects up to 1 % of the population worldwide. Currently, there are no drugs that can cure RA or achieve sustained remission. The unknown cause of the disease represents a significant challenge in the drug development. In this study, we address this challenge by proposing an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Antirheumatic Agents
Share to Arthritis, Rheumatoid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to Genome, Human

Share to Genome-Wide Association Study

Share to Genomics

Share to Systems Biology

Source

Open in PubMed Open full text

Identifiers

PMID: 27557330
DOI: 10.1186/s12864-016-2910-0
PMCID: PMC5001200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.PMID 27557330Read ↗

Integrative Multiomics Network Analysis of Genetic Risk Factors to Infer Biomarkers and Therapeutic Targets for Rheumatoid ArthritisSemantic proximity Read ↗

A network-based model for drug repurposing in Rheumatoid ArthritisSemantic proximity Read ↗

An AI Approach to Identifying Novel Therapeutics for Rheumatoid ArthritisSemantic proximity Read ↗

From the era of genome analysis to the era of genomic drug discovery: a pioneering example of rheumatoid arthritis.Semantic proximity Read ↗

Prediction of New Risk Genes and Potential Drugs for Rheumatoid Arthritis from Multiomics Data.Semantic proximity Read ↗

Genetics of rheumatoid arthritis contributes to biology and drug discovery.Semantic proximity Read ↗

Identifying therapeutic targets for rheumatoid arthritis by genomics-driven integrative approachesSemantic proximity Read ↗

A systematic method for mapping multiple loci: an application to construct a genetic network for rheumatoid arthritis.Semantic proximity Read ↗

Systematic druggable genome-wide Mendelian randomization identifies novel therapeutic targets or repurposing opportunities for rheumatoid arthritisSemantic proximity Read ↗

Integrative Analysis of Genetic, Proteomic, and Transcriptomic Data Reveals Novel Therapeutic Targets for Rheumatoid ArthritisSemantic proximity Read ↗

Compendium of Synovial Signatures Identifies Pathologic Characteristics for Predicting Treatment Response in Rheumatoid ArthritisSemantic proximity Read ↗

Knowledge-based analysis of genetic associations of rheumatoid arthritis to inform studies searching for pleiotropic genes: a literature review and network analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.